Peter S. Chan

1.8k citations

53 papers · 1.5k indexed · h-index 19

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Organic Chemistry top 5%
- Quinazolinone synthesis and applications

Papers in ⓘ

Biochemistry 6
- Eicosanoids and Hypertension Pharmacology 5
Pharmacology 10
- Inflammatory mediators and NSAID effects 7

Co-authors: Franky Leung Chan (10 shared papers)H.L. Choi (4 shared papers)Zhen‐Yu Chen (1 shared paper)Yü Huang (1 shared paper)J. Donald Albright (7 shared papers)Wai Shan Wong (2 shared papers)Fernand M.M. Lai (2 shared papers)Kwok Wai Lo (2 shared papers)
Journals: Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)The Prostate (5 papers)Thrombosis Research (3 papers)Journal of Hypertension (2 papers)
Partner nations: United States Hong Kong Canada

In The Last Decade

Peter S. Chan

53 papers receiving 1.4k citations

Peers

Countries citing papers authored by Peter S. Chan

Since Specialization

Citations

This map shows the geographic impact of Peter S. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Chan more than expected).

Fields of papers citing papers by Peter S. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Chan. The network helps show where Peter S. Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter S. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter S. Chan Line = papers co-authored together Peter S. Chan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. PubMed ·Michael W.Y. Chan, Lun W Chan, Nelson L.S. Tang, Joanna H.M. Tong, Kwok Wai Lo, TL Lee, Ho Yuen Cheung, Wai Shan Wong, Peter S. Chan, Fernand M.M. Lai, Ka‐Fai To	2002	236
2	Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin Cancer Letters ·Franky Leung Chan, H.L. Choi, Zhen‐Yu Chen, Peter S. Chan, Yü Huang	2000	211
3	5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors Journal of Medicinal Chemistry ·J. Donald Albright, Marvin F. Reich, Efren G. Delos Santos, John P. Dusza, Fuk‐Wah Sum, Aranapakam M. Venkatesan, Joseph Coupet, Peter S. Chan, Xun Ru, Hossein Mazandarani, Trina Bailey	1998	129
4	Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients International Journal of Cancer ·Michael W.Y. Chan, Lung Wai Chan, Nelson L.S. Tang, Kwok Wai Lo, Joanna H. Tong, Anthony W.H. Chan, Ho Yuen Cheung, Wai Shan Wong, Peter S. Chan, Fernand M.M. Lai, Ka‐Fai To	2003	94
5	An objective study of alternative methods of heparin administration Thrombosis Research ·P G Bentley, Vijay V. Kakkar, Michael Scully, Ian MacGregor, Peter Webb, Peter S. Chan, Nigel Jones	1980	94
6	The synthesis of 2,3-dihydro-4(1H)-quinazolinone angiotensin II receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Jeremy I. Levin, Peter S. Chan, Trina Bailey, Andrew S. Katocs, Aradhana M. Venkatesan	1994	78
7	Adaptive Resource Allocation and Capacity Comparison of Downlink Multiuser MIMO-MC-CDMA and MIMO-OFDMA IEEE Transactions on Wireless Communications ·Ernest S. Lo, Peter S. Chan, Vincent K. N. Lau, R.S. Cheng, Khaled B. Letaief, Ross Murch, Wai Ho Mow	2007	54
8	Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides Journal of Medicinal Chemistry ·William B. Wright, Jeffery B. Press, Peter S. Chan, Joseph W. Marsico, M. F. HAUG, Judy Lucas, Jess Tauber, Andrew S. Tomcufcik	1986	47
9	VPA-985, a Nonpeptide Orally Active and Selective Vasopressin V2 Receptor Antagonist Advances in experimental medicine and biology ·Peter S. Chan, Joseph Coupet, Hyung C. Park, Fong M Lai, D A Hartupee, Peter Cervoni, John P. Dusza, J. Donald Albright, Xun Ru, Hossein Mazandarani, T. Tanikella, Cherrie Shepherd, Laura Ochalski, Trina Bailey, Tim Lock, Xiaoping Ning, Joseph R. Taylor, Walter Spinelli	1998	39
10	Pyridobenzodiazepines: A novel class of orally active, vasopressin V2 receptor selective agonists Bioorganic & Medicinal Chemistry Letters ·Amedeo Failli, Jay S. Shumsky, Robert J. Steffan, Thomas J. Caggiano, David Williams, Eugene J. Trybulski, Xiaoping Ning, Yeung‐Wai Lock, T. Tanikella, David J. Hartmann, Peter S. Chan, C.H. Park	2005	37
11	In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates The Prostate ·Peter S. Chan, L.W. Chan, Jim W. Xuan, Joseph L. Chin, Hueng‐Sik Choi, Franky Leung Chan	1999	37
12	Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists Bioorganic & Medicinal Chemistry Letters ·Fuk‐Wah Sum, John P. Dusza, Efren Delos Santos, G Grosu, Marvin F. Reich, Xumei Du, J. Donald Albright, Peter S. Chan, Joseph Coupet, Xun Ru, Hossein Mazandarani, Trina Saunders	2003	34
13	Altered expression of extracellular matrix and proteinases in noble rat prostate gland after long‐term treatment with sex steroids The Prostate ·S.C. Li, G.F. Chen, Peter S. Chan, H.L. Choi, Shuk‐Mei Ho, Franky Leung Chan	2001	23
14	Recent Advances in the Discovery and Development of Vasopressin Antagonists: Peptide and Nonpeptide Vta and V2 Receptor Antagonists Current Pharmaceutical Design ·J. Donald Albright, Peter S. Chan	1997	23
15	Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones Journal of Medicinal Chemistry ·William B. Wright, Andrew S. Tomcufcik, Peter S. Chan, Joseph W. Marsico, Jeffery B. Press	1987	22
16	Prostaglandins, prostacyclin, and thromboxane in cardiovascular diseases Drug Development Research ·Peter S. Chan, Peter Cervoni	1986	19
17	PSP94 (or ?-microseminoprotein) is a secretory protein specifically expressed and synthesized in the lateral lobe of the rat prostate The Prostate ·Joseph Kwong, Jim W. Xuan, H.L. Choi, Peter S. Chan, Franky Leung Chan	2000	18
18	A Comparative Study of Hormonal Regulation of Three Secretory Proteins (Prostatic Secretory Protein-PSP94, Probasin, and Seminal Vesicle Secretion II) in Rat Lateral Prostate*This work was supported by an RGC Earmarked Research Grant (CUHK 4131/00M) from the Hong Kong Research Grant Council (to F.L.C.) and a grant from the Medical Research Council of Canada (to J.W.X.). Endocrinology* ·Joseph Kwong, Jim W. Xuan, Peter S. Chan, Shuk‐Mei Ho, Franky Leung Chan	2000	18
19	Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer Oncology Reports ·Guang Chen, Franky Leung Chan, Bao Hong, Lisa Chan, Peter S. Chan	2004	18
20	Aggressive Fibromatosis of the Spermatic Cord:A Typical Lesion in a “New” Location American Journal of Clinical Pathology ·Fernand Mac–Moune Lai, Philip W. Allen, L.W. Chan, Peter S. Chan, John E. Cooper, Tara Mackenzie	1995	16

About Peter S. Chan

Peter S. Chan is a scholar working on Biochemistry, Pharmacology, Anesthesiology and Pain Medicine, Urology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 1.5k indexed citations. Recurring topics across this work include Electrolyte and hormonal disorders (8 papers), Neuroendocrine regulation and behavior (8 papers), Inflammatory mediators and NSAID effects (7 papers), Receptor Mechanisms and Signaling (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Urologic and reproductive health conditions (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Internal Medicine (83 citations), Organic Chemistry (342 citations), Pharmacology (189 citations), Molecular Biology (690 citations) and Pulmonary and Respiratory Medicine (280 citations). Peter S. Chan has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Franky Leung Chan, H.L. Choi, Zhen‐Yu Chen, Yü Huang, J. Donald Albright, Wai Shan Wong, Fernand M.M. Lai, Kwok Wai Lo, Ho Yuen Cheung and Nelson L.S. Tang. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, The Prostate, Thrombosis Research and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact